IP Verse

Lipopeptide Compositions And Related Methods - EP2504353B2

PatentPatent Analysis

EP2504353

CUBIST PHARMACEUTICALS
Application Number
EP10832379A
Filing Date
Nov 23, 2010
Status
Patent Maintained As Amended
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2504353B2 was granted to Cubist Pharmaceuticals on Sep 13, 2023 following the initial filing on Nov 23, 2010 under the application number EP10832379A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PAJAROApr 11, 2019ADMISSIBLE
HGFApr 10, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents